Abbott Laboratories’ Volt PFA System Receives EU CE Mark for Atrial Fibrillation Treatment
US-based Abbott Laboratories (NYSE: ABT) has announced the receipt of the CE mark in the...
Abbott
GSK and Abbott Announce Leadership Changes in Key Roles
Recent days have seen significant leadership changes at two pharmaceutical giants: UK-based GSK plc (LON:...
Abbott Labs Posts Q4 Growth, Projects Strong 2025 Outlook
US-based Abbott Laboratories (NYSE: ABT) has released its Q4 2024 financial results, reporting an 8.8%...
Henlius and Abbott Sign License Agreement for Biosimilars and Biologic Drug
China-based Shanghai Henlius Biotech Inc. (HKG: 2696) has announced a strategic license agreement with Abbott...
Abbott Laboratories Expands Structural Heart Portfolio with TAVI Balloon-Expandable System
US-based Abbott Laboratories (NYSE: ABT) has announced the successful application of its transcatheter aortic valve...
Abbott Laboratories Expands Global Diabetes Care with New Kilkenny Facility
Abbott Laboratories (NYSE: ABT), a leading US healthcare company, has announced the opening of its...
OrbusNeich Medical Group Partners with Abbott’s CSI as Sole Distributor
Shenzhen-based vascular intervention specialist OrbusNeich Medical Group Ltd (HKG: 6929) has announced a significant distribution...
Abbott Laboratories Reports Q2 2024 Sales Growth of 9.3%, Led by Medical Devices and Diabetes Sales
Abbott Laboratories (NYSE: ABT), a global healthcare giant based in the US, has reported its...
Zai Lab Ltd Appoints New Greater China CCO as Liang Yi Exits
Zai Lab Ltd (NASDAQ: ZLAB; HKG: 9688) has announced the appointment of Zhu Tong as...
Abbott Reports Q1 2024 Organic Sales Growth of 4.7%, Led by Pharmaceuticals and Devices
Abbott (NYSE: ABT), a global healthcare giant, has this week announced its financial results for...
AbbVie CEO Rick González to Retire, Succeeded by Robert A. Michael
AbbVie (NYSE: ABBV), a leading US pharmaceutical company, has announced that Rick González, who has...
Abbott Reports Mixed 2023 Results with Q4 Growth Offsetting Full-Year Decline
US healthcare company Abbott (NYSE: ABT) has released its financial results for the fourth quarter...
Abbott Initiates Clinical Study for Volt PFA System in Australia for Cardiac Arrhythmias
Abbott (NYSE: ABT) has announced that the first patients have been treated with its Volt...
Abbott Reports 8.7% Drop in Q3 2023 Global Sales, Hit by Lower SARS-CoV-2 Test Demand
Abbott (NYSE: ABT) published its Q3 2023 financial results this week, reporting a 8.7% year-on-year...
Abbott Expands Biosimilars Portfolio with mAbxience In-License Agreement
Abbott (NYSE: ABT) has announced the in-licensing of several biosimilar drugs from Spain-based biotechnology firm...
Abbott to Acquire Insulin Management Firm Bigfoot Biomedical
Healthcare giant Abbott (NYSE: ABT) has announced an agreement to purchase Bigfoot Biomedical, a company...
Abbott Reports Q2 2023 Revenue Growth Exceeding Estimates Despite COVID-19 Dip
US-based life sciences firm Abbott (NYSE: ABT) has released its financial results for the second...
Abbott Partners with Sinopharm for Expanded Medical Solutions in China
US-based Abbott (NYSE: ABT) has entered into a strategic partnership with Sinopharm’s China National Medical...
Abbott’s Q4 Sales Dip Amid COVID-19 Testing Decline, China Market Updates
US-based Abbott (NYSE: ABT) released its Q4 2022 financial results last week, showing a 6.1%...
CIIE: Bo’ao Lecheng Zone Announces Partnerships with Multinationals
The 5th China International Import Expo (CIIE) saw the Bo’ao Lecheng Medical Tourism Pilot Zone...